INSTITUTE FOR GENE THERAPIES (EIN 842460457) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2019

Legal Domicile

Principal Officer

MICHAEL CAPALDI

Phone

9857079104

Tax Period

2024-01-01 to 2024-12-31

INSTITUTE FOR GENE THERAPIES, founded in 2019, is a community nonprofit in the Medical Research sector that reported $1.1M in total revenue in fiscal year 2024. Revenue fell 22% from the prior year — a significant decline worth monitoring. Expenses of $1.2M exceeded revenue, resulting in a 10% operating deficit.

Mission

INSTITUTE FOR GENE THERAPIES (IGT) AIMS TO EDUCATE ABOUT AND ADVOCATE FOR THE SCIENCE OF GENE AND CELL THERAPIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,093,333

Program Service Revenue $0

Investment Income $54

Other Revenue $0

TOTAL REVENUE $1,093,387

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $1,173,205

Other Expenses $1,207,387

TOTAL EXPENSES $1,207,387

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,093,387	$1,400,439	-0.2%
Expenses	$1,207,387	$1,158,630	+0.0%
Net Income	$-114,000	$241,809	-1.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ERIK PAULSEN	CHAIRMAN	1.00	Officer Director	$0	$0	$0
MICHAEL CAPALDI	PRESIDENT	2.00	Officer Director	$0	$0	$0
KENNETH HODGE	SECRETARY	1.00	Officer Director	$0	$0	$0
CHRISTOPHER MAY	TREASURER	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,093,387	$1,207,387	$875,245	$-114,000
2023	$1,400,439	$1,158,630	$846,401	$241,809
2022	$1,325,000	$1,103,289	$538,185	$221,711
2021	$1,200,000	$1,118,949	$285,097	$81,051
2020	$550,000	$871,510	$475,691	$-321,510
2019	$510,000	$138,823	$371,177	$371,177

INSTITUTE FOR GENE THERAPIES